L-Cycloserine
- Generic Name
- L-Cycloserine
- Brand Names
- Seromycin
- Drug Type
- Small Molecule
- Chemical Formula
- C3H6N2O2
- CAS Number
- 339-72-0
- Unique Ingredient Identifier
- AK7DRB7FMO
- Background
Antibiotic substance produced by Streptomyces garyphalus.
- Indication
本品与其他抗结核药联合，用于经一线药物（如吡嗪酰胺、链霉素、异烟肼、利福平和乙胺丁醇）治疗失败的患者。本品还可用于治疗非结核分枝杆菌感染如鸟复合分枝杆菌病的治疗。
- Associated Conditions
- Pulmonary Tuberculosis (TB), Tuberculosis, Extrapulmonary, Grade 1, grade 2, grade 3, grade 4 Urinary Tract Infection
- Associated Therapies
- -
NRx Pharmaceuticals Reports Third Quarter and Year to Date 2024
NRx Pharmaceuticals plans to file New Drug Applications (NDAs) for NRX-100 (IV Ketamine) in treating suicidal ideation in depression and NRX-101 (Oral D-Cycloserine/Lurasidone) for Accelerated Approval in bipolar depression with suicidality or akathisia by year-end 2024, with a 2025 PDUFA date forecast. HOPE Therapeutics, a subsidiary, is acquiring Interventional Psychiatry Clinics to develop a best-in-class network of care, expecting first revenue by year-end 2024. The company reduced net operating losses by 74% compared to Q3 2023 and forecasts profitability in 2025. A conference call is scheduled for November 18, 2024, at 4:30 PM ET.
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath